Crescita Therapeutics Inc. (TSX:CTX)

Crescita Therapeutics Statistics

Total Valuation

TSX:CTX has a market cap or net worth of CAD 9.05 million. The enterprise value is 1.22 million.

Market Cap	9.05M
Enterprise Value	1.22M

Important Dates

The last earnings date was Friday, November 7, 2025.

Earnings Date	Nov 7, 2025
Ex-Dividend Date	n/a

Share Statistics

TSX:CTX has 18.85 million shares outstanding. The number of shares has decreased by -2.70% in one year.

Current Share Class	18.85M
Shares Outstanding	18.85M
Shares Change (YoY)	-2.70%
Shares Change (QoQ)	-0.99%
Owned by Insiders (%)	13.31%
Owned by Institutions (%)	n/a
Float	16.34M

Valuation Ratios

The trailing PE ratio is 23.61.

PE Ratio	23.61
Forward PE	n/a
PS Ratio	0.41
PB Ratio	0.56
P/TBV Ratio	0.62
P/FCF Ratio	14.52
P/OCF Ratio	4.45
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.04, with an EV/FCF ratio of 1.96.

EV / Earnings	2.68
EV / Sales	0.06
EV / EBITDA	2.04
EV / EBIT	n/a
EV / FCF	1.96

Financial Position

The company has a current ratio of 3.12, with a Debt / Equity ratio of 0.03.

Current Ratio	3.12
Quick Ratio	2.00
Debt / Equity	0.03
Debt / EBITDA	0.72
Debt / FCF	0.78
Interest Coverage	-15.96

Financial Efficiency

Return on equity (ROE) is 2.83% and return on invested capital (ROIC) is -2.90%.

Return on Equity (ROE)	2.83%
Return on Assets (ROA)	-2.21%
Return on Invested Capital (ROIC)	-2.90%
Return on Capital Employed (ROCE)	-4.79%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	62
Asset Turnover	1.00
Inventory Turnover	1.85

Taxes

Income Tax	-14,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.24% in the last 52 weeks. The beta is 0.32, so TSX:CTX's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-17.24%
50-Day Moving Average	0.46
200-Day Moving Average	0.51
Relative Strength Index (RSI)	57.28
Average Volume (20 Days)	27,299

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:CTX had revenue of CAD 22.07 million and earned 457,000 in profits. Earnings per share was 0.02.

Revenue	22.07M
Gross Profit	11.42M
Operating Income	-782,000
Pretax Income	443,000
Net Income	457,000
EBITDA	249,000
EBIT	-782,000
Earnings Per Share (EPS)	0.02

Balance Sheet

The company has 8.31 million in cash and 484,000 in debt, giving a net cash position of 7.82 million or 0.42 per share.

Cash & Cash Equivalents	8.31M
Total Debt	484,000
Net Cash	7.82M
Net Cash Per Share	0.42
Equity (Book Value)	16.26M
Book Value Per Share	0.86
Working Capital	10.86M

Cash Flow

In the last 12 months, operating cash flow was 2.03 million and capital expenditures -1.41 million, giving a free cash flow of 623,000.

Operating Cash Flow	2.03M
Capital Expenditures	-1.41M
Free Cash Flow	623,000
FCF Per Share	0.03

Margins

Gross margin is 51.77%, with operating and profit margins of -3.54% and 2.07%.

Gross Margin	51.77%
Operating Margin	-3.54%
Pretax Margin	2.01%
Profit Margin	2.07%
EBITDA Margin	1.13%
EBIT Margin	-3.54%
FCF Margin	2.82%

Dividends & Yields

TSX:CTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.70%
Shareholder Yield	2.70%
Earnings Yield	5.05%
FCF Yield	6.89%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5